Sign In

Sam Jactel

Ayble Health | Ginkgo | Kellogg | Accenture

Sam Jactel is a dedicated individual with a passion for making scientific knowledge accessible to those in need.

His educational background includes a Master of Business Administration (MBA) from Northwestern University's Kellogg School of Management, a Bachelor's degree in Biology from Duke University, participation in the 2022 ADAPT Program at UCSF Rosenman Institute, a Bachelor of Science in Biology from UNSW, and an IB Bilingual Diploma from Atlanta International School.

Throughout his career, Sam has been associated with various esteemed organizations. He has served as an Invited Lecturer at Columbia University Mailman School of Public Health, Member of the Board of Directors at Hypercell Technologies, Strategic Advisor at Pertinent Eco-Solutions, Founder & CEO of Ayble Health, and in roles like Growth Strategy at Ginkgo Bioworks, Inc., Flare Scholar at Flare Capital Partners, Business Strategy Consultant at Accenture, Global Commercial Strategy at Genzyme, and Sr. Pathology Researcher at Children's Healthcare of Atlanta.

Highlights

Feb 1 · linkedin

🏆 Proud to officially announce that Ayble Health is recognized as the first and only gastroenterology company to achieve certification from the Validation Institute! Click here https://lnkd.in/enwzA7xV for our announcement & https://lnkd.in/eiFaSqVf for our outcomes validation!

Highlights:

  • 81% of IBD and IBS patients using Ayble significantly improve their clinical symptoms
  • 89% of users report significantly better quality of life, 95% improve their ability to make healthy digestive choices and 89% feel more empowered and in control of their digestive health
  • 89% of Ayble users are adherent to program recommendations, with a 92% average satisfaction score ‍ Compared to the current gold-standard of care in gastroenterology, The Validation Institute’s Outcomes Report also emphasizes that Ayble’s precision nutrition program:
  • Is 2x more effective as in-person or virtual dietetics, measured by symptom improvement
  • Drives 30-40% better adherence to recommendations

Employers and insurers, we're ready to help manage the gut health of your employees & members - there are more of us than you think, and we're sicker than you'd expect. This Validation comes with a $25,000 Credibility Guarantee (https://lnkd.in/eeHVpWzG), so we're putting our money where our mouth is.

At Ayble Health we've been laser focused on evidence-based management of #gastroenterology. This validation is a testament to the two decades of peer-reviewed research investigating GI-specific dietary and psychological management of IBS & IBD, as well as three years of our own published primary clinical research with Northwestern University - The Feinberg School of Medicine Harvard Medical School, Cleveland Clinic, Mayo Clinic Health System and many others.

“The clinical results we found with Ayble Health are exceptional. We are thrilled to recognize Ayble Health as the first and only GI company to receive our validation and are excited to see such a robust program be launched for a patient population that has been long overlooked,” Benny DiCecca, CEO of the Validation Institute.

Founder Collective M13 🚀 Upfront Ventures Inflect Health Northwestern University - Kellogg School of Management UCSF Rosenman Institute

Related Questions

What are Sam Jactel's main areas of expertise?
How did Sam Jactel start his career in healthcare?
What is Ayble Health's mission and focus?
What partnerships has Ayble Health formed recently?
How has Sam Jactel's work impacted healthcare innovation?
Sam Jactel
Sam Jactel, photo 1
Sam Jactel, photo 2
Add to my network

Location

Boston, Massachusetts, United States